Alembic Pharmaceuticals

Alembic Pharmaceuticals Limited receives USFDA Final Approval for Triamcinolone Acentonide Injectable Suspension USP, 40 mg/mL (Single - Dose and Multiple - Dose Vials)

18 Oct, 2025 | 06:02pm • Source: BSE

Please find attached Newspaper Publication for Special Window for re-lodgement of transfer of physical shares.

15 Oct, 2025 | 05:09pm • Source: BSE

Please find attached herewith intimation regarding copy of newspaper advertisement related to notice for claiming shares from Company''s Unclaimed Suspense Account.

07 Oct, 2025 | 04:03pm • Source: BSE

Please find attached herewith the Certificate under 74(5) of SEBI (DP)Regulations, 2018 for the quarter ended 30th September, 2025.

06 Oct, 2025 | 06:07pm • Source: BSE

Alembic Pharmaceuticals Limited has informed the Exchange about General Updates - Intimation for change of email address of the Registrar and Share Transfer Agent (...

01 Oct, 2025 | 10:22am • Source: NSE

We have been informed by our RTA that they have introduced a new generic email ID w.e.f. 1st October, 2025.

01 Oct, 2025 | 09:55am • Source: BSE

Please find enclosed herewith newspaper publication of Saksham Niveshak

30 Sep, 2025 | 06:53pm • Source: BSE

Intimation of closure of trading window

26 Sep, 2025 | 05:30pm • Source: BSE

The Company has received USFDA Final approval for Paroxetine Extended- Release Tablets USP 25 mg and 37.5 mg.

25 Sep, 2025 | 12:37pm • Source: BSE

Please find attached herewith, a copy of advertisement related to notice of loss of equity share certificate published by Company in newspaper.

15 Sep, 2025 | 07:04pm • Source: BSE

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 09, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Phytonadione...

09 Sep, 2025 | 11:00am • Source: NSE

Alembic Pharmaceuticals Limited receives USFDA Final Approval for Phytonadione Injectable Emulsion USP, 1 mg/0.5 mL Single Dose Prefilled Syringe

09 Sep, 2025 | 10:50am • Source: BSE

Alembic Pharmaceuticals Limited has informed the Exchange about Schedule of meet

29 Aug, 2025 | 11:14am • Source: NSE

Please find attached herewith the Intimation under Regulation 30 of SEBI LODR Regulations, 2015- Analysts / Investor Meet

29 Aug, 2025 | 10:49am • Source: BSE

Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets, 10mg.

19 Aug, 2025 | 11:14am • Source: BSE

As attached.

18 Aug, 2025 | 07:57pm • Source: BSE

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Analysts / Investors Meeting

18 Aug, 2025 | 06:12pm • Source: BSE

Please find attached herewith the Transcript of Post Result Conference Call held on 5th August, 2025

11 Aug, 2025 | 07:36pm • Source: BSE

Newspaper Publications of Unaudited Financials Results

06 Aug, 2025 | 05:33pm • Source: BSE

Please find attached the intimation for appointment of Secretarial Auditors.

05 Aug, 2025 | 11:17pm • Source: BSE